GeoPharma, Inc. Completes Recapitalization and Restructuring
05 août 2010 12h01 HE
|
GeoPharma, Inc.
LARGO, Fla., Aug. 5, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Pink Sheets:GORX) today announced that, on Monday August 2, 2010, the Company completed a recapitalization and restructuring designed to...
GeoPharma Reduces Senior Convertible Debt
21 avr. 2010 10h30 HE
|
GeoPharma, Inc.
LARGO, Fla., April 21, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that since December 31, 2009, it has reduced its 12% convertible debt (the "Debt") owed to...
GeoPharma Announces the Acceptability of Their Largo Cephalosporin Plant
02 mars 2010 11h27 HE
|
GeoPharma, Inc.
LARGO, Fla., March 2, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that the FDA Office of Compliance has completed the evaluation of its Largo, Florida...
GeoPharma Announces Fiscal Year 2010 Third Quarter Results Conference Call
01 mars 2010 13h27 HE
|
GeoPharma, Inc.
LARGO, Fla., March 1, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") is hosting a conference call on March 2, 2010 at 11 a.m. ET to discuss the Fiscal Year 2010 Third Quarter...
GeoPharma Announces Fiscal Year 2010 Third Quarter Results and Conference Call
23 févr. 2010 07h55 HE
|
GeoPharma, Inc.
LARGO, Fla., Feb. 23, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 third quarter which ended December 31, 2009, with...
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Stockholders' Equity Requirement
03 déc. 2009 08h30 HE
|
GeoPharma, Inc.
LARGO, Fla., Dec. 3, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a NASDAQ Staff Deficiency Letter on November 25th, 2009 indicating that the...
GeoPharma Announces Fiscal Year 2010 Second Quarter Results and Conference Call
24 nov. 2009 06h55 HE
|
GeoPharma, Inc.
LARGO, Fla., Nov. 24, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 second quarter which ended September 30, 2009, with...
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
18 sept. 2009 18h00 HE
|
GeoPharma, Inc.
LARGO, Fla., Sept. 18, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a Nasdaq Staff Deficiency Letter on September 15th, 2009 indicating that the...
GeoPharma Announces Settlement of Baltimore Beta-Lactam Antibiotics Facility Litigation
08 sept. 2009 07h00 HE
|
GeoPharma, Inc.
LARGO, Fla., Sept. 8, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it, through its subsidiary, American Antibiotics, LLC (collectively, "AA Parties") has...
GeoPharma Announces Fiscal Year 2010 First Quarter Results and Conference Call
17 août 2009 07h00 HE
|
GeoPharma, Inc.
LARGO, Fla., Aug. 17, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 first quarter.
Commenting on the quarter GeoPharma...